147 related articles for article (PubMed ID: 22888341)
1. Effect of non-anticoagulant N-desulfated heparin on basic fibroblast growth factor expression, angiogenesis, and metastasis of gastric carcinoma in vitro and in vivo.
Chen JL; Fan J; Chen MX; Dong Y; Gu JZ
Gastroenterol Res Pract; 2012; 2012():752940. PubMed ID: 22888341
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of bFGF gene expression and tumor angiogenesis of orthotopic implantation of human gastric carcinoma by N-desulfated heparin].
Chen MX; Chen JL; Lu JL; Hong J; Chen WX; Zhu JS; Chen NW; Geng JG
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):78-81. PubMed ID: 18247311
[TBL] [Abstract][Full Text] [Related]
3. Effect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma.
Chen JL; Hong J; Lu JL; Chen MX; Chen WX; Zhu JS; Chen NW; Chen GQ; Geng JG
World J Gastroenterol; 2007 Jan; 13(3):457-61. PubMed ID: 17230619
[TBL] [Abstract][Full Text] [Related]
4. Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor.
Kariya Y; Kyogashima M; Suzuki K; Isomura T; Sakamoto T; Horie K; Ishihara M; Takano R; Kamei K; Hara S
J Biol Chem; 2000 Aug; 275(34):25949-58. PubMed ID: 10837484
[TBL] [Abstract][Full Text] [Related]
5. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
Rusnati M; Coltrini D; Caccia P; Dell'Era P; Zoppetti G; Oreste P; Valsasina B; Presta M
Biochem Biophys Res Commun; 1994 Aug; 203(1):450-8. PubMed ID: 8074689
[TBL] [Abstract][Full Text] [Related]
6. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
[TBL] [Abstract][Full Text] [Related]
7. Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix.
Ishai-Michaeli R; Svahn CM; Weber M; Chajek-Shaul T; Korner G; Ekre HP; Vlodavsky I
Biochemistry; 1992 Feb; 31(7):2080-8. PubMed ID: 1536850
[TBL] [Abstract][Full Text] [Related]
8. Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats.
Zhou T; Chen JL; Song W; Wang F; Zhang MJ; Ni PH; Geng JG
World J Gastroenterol; 2002 Oct; 8(5):897-900. PubMed ID: 12378638
[TBL] [Abstract][Full Text] [Related]
9. N-desulfated heparin improves concanavalin A-induced liver injury partly through inhibiting T lymphocyte adhesion.
Yuan L; Geng JG; Xu Q
Inflamm Res; 2003 Sep; 52(9):383-9. PubMed ID: 14504666
[TBL] [Abstract][Full Text] [Related]
10. Association of heparin with basic fibroblast growth factor, epidermal growth factor, and constitutive nitric oxide synthase on healing of gastric ulcer in rats.
Li Y; Wang HY; Cho CH
J Pharmacol Exp Ther; 1999 Aug; 290(2):789-96. PubMed ID: 10411593
[TBL] [Abstract][Full Text] [Related]
11. Antimetastatic effects associated with anticoagulant properties of heparin and chemically modified heparin species in a mouse mammary tumor model.
Alonso D; Bertolesi G; Farias E; Eijan A; Joffe E; Decidre L
Oncol Rep; 1996 Jan; 3(1):219-22. PubMed ID: 21594348
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer.
Zhang W; Chu YQ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2009 Aug; 292(8):1114-21. PubMed ID: 19533745
[TBL] [Abstract][Full Text] [Related]
13. N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo.
Wan JG; Mu JS; Zhu HS; Geng JG
Inflamm Res; 2002 Sep; 51(9):435-43. PubMed ID: 12365716
[TBL] [Abstract][Full Text] [Related]
14. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
Lundin L; Larsson H; Kreuger J; Kanda S; Lindahl U; Salmivirta M; Claesson-Welsh L
J Biol Chem; 2000 Aug; 275(32):24653-60. PubMed ID: 10816596
[TBL] [Abstract][Full Text] [Related]
15. N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation.
Purkerson ML; Tollefsen DM; Klahr S
J Clin Invest; 1988 Jan; 81(1):69-74. PubMed ID: 3335644
[TBL] [Abstract][Full Text] [Related]
16. Basic-fibroblast-growth-factor-mediated de novo angiogenesis is more effectively suppressed by low-molecular-weight than by high-molecular-weight heparin.
Norrby K; Ostergaard P
Int J Microcirc Clin Exp; 1996; 16(1):8-15. PubMed ID: 8739219
[TBL] [Abstract][Full Text] [Related]
17. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
18. [Effect of angiogenesis inhibitor SU6668 on the growth and metastasis of gastric cancer in SCID mice].
Jiang XT; Tao HQ; Zou SC
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):335-7. PubMed ID: 16886118
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins.
Bertolesi GE; Lauría de Cidre L; Eiján AM
Tumour Biol; 1994; 15(5):275-83. PubMed ID: 7991988
[TBL] [Abstract][Full Text] [Related]
20. Effect of 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid in combination with carboplatin on gastric carcinoma growth in vivo.
Chen JL; Zhu JS; Hong J; Chen MX; Lu JL; Chen WX; Shen B; Zhu ZM; Chen NW
World J Gastroenterol; 2007 Jan; 13(4):509-14. PubMed ID: 17278215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
